Genetic polymorphisms in miRNAs targeting the estrogen receptor and their effect on breast cancer risk

Meta Gene

Volumn 2, Issue 1, 2014, Pages 226-236

  Nguyen Dien, Giang T ^a,b   Smith, Robert A ^a   Haupt, Larisa M ^a   Griffiths, Lyn R ^a   Nguyen, Hue T ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b INTERNATIONAL UNIVERSITY   (Viet Nam)

Author keywords

Breast cancer; miR 148a; miR 152; miR 186; miR 221; SNP

Indexed keywords

ESTROGEN RECEPTOR; MICRORNA; MICRORNA 148A; MICRORNA 152; MICRORNA 186; MICRORNA 221; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR ALPHA;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE TARGETING; GENETIC ASSOCIATION; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; AUSTRALIAN; CANCER GROWTH; FAMILY HISTORY; GEL ELECTROPHORESIS; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; SEQUENCE ANALYSIS;

EID: 84901769950     PISSN: None     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2014.01.002     Document Type: Article

References (23)

1. Catucci, I., Yang, R., et al., 2010. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum. Mutat. 31 (1), E1052-E1057.
2. Ferlay, J., Shin, H.R., et al., 2010. GLOBOCAN 2008 v2.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France (Available from: http://globocan.iarc.fr).
3. Friedman, R.C., Farh, K.K., et al., 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (1), 92-105.
4. Guttilla, I.K., White, B.A., 2009. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem. 284 (35), 23204-23216.
5. Heneghan, H.M., Miller, N., et al., 2009. MicroRNAs as novel biomarkers for breast cancer. J. Oncol. 2009, 950201.
6. Hossain, A., Kuo, M.T., et al., 2006. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol. 26 (21), 8191-8201.
7. Iorio, M.V., Ferracin, M., et al., 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (16), 7065-7070.
8. Jackson, R.J., Standart, N., 2007. How do microRNAs regulate gene expression? Sci. STKE 2007 (367), re1.
9. Kontorovich, T., Levy, A., et al., 2010. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int. J. Cancer 127 (3), 589-597.
10. Lu, J., Getz, G., et al., 2005. MicroRNA expression profiles classify human cancers. Nature 435 (7043), 834-838.
11. Nassirpour, R., Mehta, P.P., et al., 2013. miR-221 promotes tumorigenesis in human triple negative breast cancer cells. PLoS One 8 (4), e62170.
12. Pastrello, C., Polesel, J., et al., 2010. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 31 (12), 2124-2126.
13. Si, M.L., Zhu, S., et al., 2007. miR-21-mediated tumor growth. Oncogene 26 (19), 2799-2803.
14. Slaby, O., Bienertova-Vasku, J., et al., 2012. Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J. Cell. Mol. Med. 16 (1), 8-21.
15. Smith, R.A., Jedlinski, D.J., et al., 2012. A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics 9 (3), 115-118.
16. Tsuchiya, Y., Nakajima, M., et al., 2006. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res. 66 (18), 9090-9098.
17. Wang, L., Liu, W., et al., 2012. A miRNA binding site single-nucleotide polymorphism in the 3'-UTR region of the IL23R gene is associated with breast cancer. PLoS One 7 (12), e49823.
18. Xu, Q., Jiang, Y., et al., 2013. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J. Mol. Cell Biol. 5 (1), 3-13.
19. Yu, J., Li, Q., et al., 2011. MiR-148a inhibits angiogenesis by targeting ERBB3. J. Biomed. Res. 25 (3), 170-177.
20. Zhang, B., Pan, X., et al., 2007. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302 (1), 1-12.
21. Zhang, L., Liu, Y., et al., 2011. Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc. Natl. Acad. Sci. U. S. A. 108 (33), 13653-13658.
22. Zheng, H., Song, F., et al., 2011. Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. Int. J. Oncol. 38 (4), 1153-1161.
23. Zhou, L., Qi, X., et al., 2008. MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript. J. Biol. Chem. 283 (42), 28274-28286.